| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 5.29e-09 | 22 | 20 | 4 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 5.29e-09 | 22 | 20 | 4 | GO:0003756 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 4.22e-08 | 36 | 20 | 4 | GO:0015035 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 8.81e-08 | 43 | 20 | 4 | GO:0015036 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 2.79e-07 | 57 | 20 | 4 | GO:0016860 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 2.79e-07 | 57 | 20 | 4 | GO:0016667 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.56e-05 | 192 | 20 | 4 | GO:0016853 | |
| GeneOntologyMolecularFunction | integrin binding | 6.76e-04 | 175 | 20 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.65e-03 | 599 | 20 | 4 | GO:0050839 | |
| GeneOntologyBiologicalProcess | positive regulation of protein folding | 8.92e-06 | 5 | 20 | 2 | GO:1903334 | |
| GeneOntologyBiologicalProcess | protein folding in endoplasmic reticulum | 6.92e-05 | 13 | 20 | 2 | GO:0034975 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 8.07e-05 | 14 | 20 | 2 | GO:1903332 | |
| GeneOntologyBiologicalProcess | protein folding | 8.23e-05 | 246 | 20 | 4 | GO:0006457 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-7 | 1.86e-04 | 21 | 20 | 2 | GO:0098761 | |
| GeneOntologyBiologicalProcess | response to interleukin-7 | 2.04e-04 | 22 | 20 | 2 | GO:0098760 | |
| GeneOntologyCellularComponent | endoplasmic reticulum chaperone complex | 6.74e-05 | 13 | 20 | 2 | GO:0034663 | |
| GeneOntologyCellularComponent | pigment granule | 1.64e-04 | 113 | 20 | 3 | GO:0048770 | |
| GeneOntologyCellularComponent | melanosome | 1.64e-04 | 113 | 20 | 3 | GO:0042470 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 2.21e-04 | 125 | 20 | 3 | GO:0140534 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.48e-04 | 332 | 20 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 8.78e-04 | 46 | 20 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | cell surface | 3.34e-03 | 1111 | 20 | 5 | GO:0009986 | |
| HumanPheno | Flexion contracture of finger | 3.99e-04 | 240 | 4 | 3 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 3.99e-04 | 240 | 4 | 3 | HP:0010563 | |
| HumanPheno | Camptodactyly of toe | 3.99e-04 | 240 | 4 | 3 | HP:0001836 | |
| HumanPheno | Joint contractures involving the joints of the feet | 3.99e-04 | 240 | 4 | 3 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 3.99e-04 | 240 | 4 | 3 | HP:0100490 | |
| HumanPheno | Flexion contracture of toe | 3.99e-04 | 240 | 4 | 3 | HP:0005830 | |
| HumanPheno | Interphalangeal joint contracture of finger | 3.99e-04 | 240 | 4 | 3 | HP:0001220 | |
| HumanPheno | Toe joint contracture | 4.04e-04 | 241 | 4 | 3 | HP:0034675 | |
| HumanPheno | Flexion contracture of finger | 4.89e-04 | 257 | 4 | 3 | HP:0012785 | |
| HumanPheno | Finger joint contracture | 5.00e-04 | 259 | 4 | 3 | HP:0034681 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 5.18e-04 | 262 | 4 | 3 | HP:0006261 | |
| HumanPheno | Pedal edema | 6.53e-04 | 54 | 4 | 2 | HP:0010741 | |
| HumanPheno | Expressive language delay | 7.02e-04 | 56 | 4 | 2 | HP:0002474 | |
| HumanPheno | Language delay | 7.02e-04 | 56 | 4 | 2 | HP:0002336 | |
| HumanPheno | Joint contractures | 7.14e-04 | 292 | 4 | 3 | HP:0001372 | |
| HumanPheno | Joint contracture of the hand | 7.44e-04 | 296 | 4 | 3 | HP:0009473 | |
| HumanPheno | Abnormal pitch | 8.06e-04 | 60 | 4 | 2 | HP:5200005 | |
| HumanPheno | Hip contracture | 8.61e-04 | 62 | 4 | 2 | HP:0003273 | |
| HumanPheno | Foot joint contracture | 1.06e-03 | 334 | 4 | 3 | HP:0008366 | |
| HumanPheno | Abnormal Intonation | 1.07e-03 | 69 | 4 | 2 | HP:5200010 | |
| HumanPheno | Camptodactyly | 1.18e-03 | 346 | 4 | 3 | HP:0012385 | |
| HumanPheno | Upper-limb joint contracture | 1.35e-03 | 362 | 4 | 3 | HP:0100360 | |
| HumanPheno | Flexion contracture of digit | 1.35e-03 | 362 | 4 | 3 | HP:0030044 | |
| HumanPheno | Limited hip movement | 1.36e-03 | 78 | 4 | 2 | HP:0008800 | |
| HumanPheno | Abnormal prosody | 1.50e-03 | 82 | 4 | 2 | HP:0031434 | |
| HumanPheno | Abnormality of the dentition | 1.66e-03 | 1030 | 4 | 4 | HP:0000164 | |
| HumanPheno | Lower-limb joint contracture | 1.85e-03 | 403 | 4 | 3 | HP:0005750 | |
| HumanPheno | Scoliosis | 2.34e-03 | 1122 | 4 | 4 | HP:0002650 | |
| Domain | Disulphide_isomerase | 6.67e-11 | 8 | 20 | 4 | IPR005788 | |
| Domain | Thioredoxin | 6.79e-10 | 13 | 20 | 4 | IPR005746 | |
| Domain | Thioredoxin_CS | 2.25e-09 | 17 | 20 | 4 | IPR017937 | |
| Domain | Prot_disulphide_isomerase | 4.20e-09 | 4 | 20 | 3 | IPR005792 | |
| Domain | THIOREDOXIN_1 | 1.19e-08 | 25 | 20 | 4 | PS00194 | |
| Domain | Thioredoxin | 2.95e-08 | 31 | 20 | 4 | PF00085 | |
| Domain | Thioredoxin_domain | 9.44e-08 | 41 | 20 | 4 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 1.15e-07 | 43 | 20 | 4 | PS51352 | |
| Domain | - | 7.74e-06 | 122 | 20 | 4 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 1.06e-05 | 132 | 20 | 4 | IPR012336 | |
| Domain | ER_TARGET | 1.65e-05 | 47 | 20 | 3 | PS00014 | |
| Domain | PWWP | 2.05e-04 | 20 | 20 | 2 | SM00293 | |
| Domain | PWWP | 2.72e-04 | 23 | 20 | 2 | PF00855 | |
| Domain | PWWP_dom | 2.72e-04 | 23 | 20 | 2 | IPR000313 | |
| Domain | PWWP | 2.96e-04 | 24 | 20 | 2 | PS50812 | |
| Domain | Zinc_finger_PHD-type_CS | 2.18e-03 | 65 | 20 | 2 | IPR019786 | |
| Domain | PHD | 2.88e-03 | 75 | 20 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 3.19e-03 | 79 | 20 | 2 | IPR019787 | |
| Domain | PHD | 4.03e-03 | 89 | 20 | 2 | SM00249 | |
| Domain | Znf_PHD | 4.21e-03 | 91 | 20 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.58e-03 | 95 | 20 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 4.68e-03 | 96 | 20 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.07e-02 | 147 | 20 | 2 | IPR011011 | |
| Domain | - | 1.16e-02 | 449 | 20 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.23e-02 | 459 | 20 | 3 | IPR013083 | |
| Pubmed | 1.19e-12 | 6 | 20 | 4 | 16677074 | ||
| Pubmed | Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env. | 1.19e-12 | 6 | 20 | 4 | 15644496 | |
| Pubmed | 2.78e-12 | 7 | 20 | 4 | 17301129 | ||
| Pubmed | Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase. | 2.78e-12 | 7 | 20 | 4 | 20458450 | |
| Pubmed | 2.78e-12 | 7 | 20 | 4 | 12218051 | ||
| Pubmed | Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection. | 2.78e-12 | 7 | 20 | 4 | 23206338 | |
| Pubmed | 5.56e-12 | 8 | 20 | 4 | 12218052 | ||
| Pubmed | Proteins of the PDI family: unpredicted non-ER locations and functions. | 5.56e-12 | 8 | 20 | 4 | 12384992 | |
| Pubmed | Elevated expression of PDI family proteins during differentiation of mouse F9 teratocarcinoma cells. | 1.63e-10 | 3 | 20 | 3 | 9493907 | |
| Pubmed | 1.62e-09 | 5 | 20 | 3 | 16182193 | ||
| Pubmed | Disulphide production by Ero1α-PDI relay is rapid and effectively regulated. | 3.25e-09 | 6 | 20 | 3 | 20802462 | |
| Pubmed | 9.09e-09 | 8 | 20 | 3 | 22230366 | ||
| Pubmed | Mapping of three members of the mouse protein disulfide isomerase family. | 3.57e-08 | 12 | 20 | 3 | 9457688 | |
| Pubmed | Mapping wild-type and R345W fibulin-3 intracellular interactomes. | 2.49e-07 | 22 | 20 | 3 | 27777122 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 9399589 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 2295602 | ||
| Pubmed | P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas. | 3.14e-07 | 2 | 20 | 2 | 29207176 | |
| Pubmed | ALS-linked protein disulfide isomerase variants cause motor dysfunction. | 3.14e-07 | 2 | 20 | 2 | 26869642 | |
| Pubmed | Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. | 5.89e-07 | 29 | 20 | 3 | 12643545 | |
| Pubmed | Regulation of perforin lysis: implications for protein disulfide isomerase proteins. | 9.42e-07 | 3 | 20 | 2 | 19147124 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 21159867 | ||
| Pubmed | The C-terminal CGHC motif of protein disulfide isomerase supports thrombosis. | 9.42e-07 | 3 | 20 | 2 | 26529254 | |
| Pubmed | An interaction map of endoplasmic reticulum chaperones and foldases. | 1.88e-06 | 4 | 20 | 2 | 22665516 | |
| Pubmed | KDEL Receptor 1 Contributes to Cell Surface Association of Protein Disulfide Isomerases. | 1.88e-06 | 4 | 20 | 2 | 30958660 | |
| Pubmed | 2.53e-06 | 730 | 20 | 6 | 34857952 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 21057456 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 10436013 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 24599957 | ||
| Pubmed | 3.53e-06 | 52 | 20 | 3 | 26499835 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 19995400 | ||
| Pubmed | The disulfide isomerase ERp72 supports arterial thrombosis in mice. | 4.71e-06 | 6 | 20 | 2 | 28576878 | |
| Pubmed | Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. | 1.13e-05 | 9 | 20 | 2 | 17055437 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 21670307 | ||
| Pubmed | Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. | 1.25e-05 | 79 | 20 | 3 | 17081065 | |
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 36427672 | ||
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 12475965 | ||
| Pubmed | A two-dimensional gel database of human colon carcinoma proteins. | 3.28e-05 | 15 | 20 | 2 | 9150948 | |
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 34487921 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 23245351 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 16416089 | ||
| Pubmed | IL-7-induced phosphorylation of the adaptor Crk-like and other targets. | 5.34e-05 | 19 | 20 | 2 | 29581031 | |
| Pubmed | 6.35e-05 | 136 | 20 | 3 | 22304920 | ||
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 30503554 | ||
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 8.33e-05 | 149 | 20 | 3 | 26370502 | |
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 9.35e-05 | 25 | 20 | 2 | 17170699 | |
| Pubmed | Human liver protein map: a reference database established by microsequencing and gel comparison. | 1.18e-04 | 28 | 20 | 2 | 1286669 | |
| Pubmed | 1.21e-04 | 457 | 20 | 4 | 22190034 | ||
| Pubmed | 1.32e-04 | 174 | 20 | 3 | 32149426 | ||
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.50e-04 | 182 | 20 | 3 | 30711629 | |
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 1.85e-04 | 35 | 20 | 2 | 29104064 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 1.92e-04 | 516 | 20 | 4 | 36610398 | |
| Pubmed | 2.07e-04 | 37 | 20 | 2 | 34225486 | ||
| Pubmed | 2.17e-04 | 1007 | 20 | 5 | 34597346 | ||
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 2.66e-04 | 221 | 20 | 3 | 31950832 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 3.00e-04 | 580 | 20 | 4 | 35676659 | |
| Pubmed | 3.06e-04 | 1084 | 20 | 5 | 11544199 | ||
| Pubmed | 4.14e-04 | 257 | 20 | 3 | 31046837 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.90e-04 | 1201 | 20 | 5 | 35696571 | |
| Pubmed | Inhibition of N-glycan processing modulates the network of EDEM3 interactors. | 4.92e-04 | 57 | 20 | 2 | 28366632 | |
| Pubmed | 5.09e-04 | 58 | 20 | 2 | 15952740 | ||
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 5.43e-04 | 282 | 20 | 3 | 35007762 | |
| Interaction | CALR3 interactions | 1.05e-05 | 142 | 20 | 4 | int:CALR3 | |
| Interaction | ERO1B interactions | 2.12e-05 | 55 | 20 | 3 | int:ERO1B | |
| Interaction | DNAJB14 interactions | 3.68e-05 | 66 | 20 | 3 | int:DNAJB14 | |
| Interaction | DNAJC18 interactions | 5.39e-05 | 75 | 20 | 3 | int:DNAJC18 | |
| Interaction | DNAJC30 interactions | 5.53e-05 | 217 | 20 | 4 | int:DNAJC30 | |
| Interaction | DNAJC3 interactions | 6.48e-05 | 226 | 20 | 4 | int:DNAJC3 | |
| Interaction | DNAJC16 interactions | 7.29e-05 | 233 | 20 | 4 | int:DNAJC16 | |
| Interaction | PLD4 interactions | 7.30e-05 | 83 | 20 | 3 | int:PLD4 | |
| Interaction | EPHA10 interactions | 8.12e-05 | 86 | 20 | 3 | int:EPHA10 | |
| Interaction | MTTP interactions | 1.58e-04 | 19 | 20 | 2 | int:MTTP | |
| Interaction | PTPRN interactions | 2.02e-04 | 117 | 20 | 3 | int:PTPRN | |
| Interaction | EDEM3 interactions | 2.02e-04 | 117 | 20 | 3 | int:EDEM3 | |
| Interaction | TMEM106B interactions | 2.16e-04 | 309 | 20 | 4 | int:TMEM106B | |
| Interaction | IDS interactions | 2.18e-04 | 120 | 20 | 3 | int:IDS | |
| Interaction | HSPA13 interactions | 2.29e-04 | 122 | 20 | 3 | int:HSPA13 | |
| Interaction | EFEMP1 interactions | 2.34e-04 | 123 | 20 | 3 | int:EFEMP1 | |
| Interaction | PTPRU interactions | 2.40e-04 | 124 | 20 | 3 | int:PTPRU | |
| Interaction | SDF2L1 interactions | 2.53e-04 | 322 | 20 | 4 | int:SDF2L1 | |
| Interaction | PDIA6 interactions | 2.68e-04 | 327 | 20 | 4 | int:PDIA6 | |
| Interaction | ERO1A interactions | 2.89e-04 | 132 | 20 | 3 | int:ERO1A | |
| Interaction | CALU interactions | 2.98e-04 | 336 | 20 | 4 | int:CALU | |
| Interaction | ERN2 interactions | 3.00e-04 | 26 | 20 | 2 | int:ERN2 | |
| Interaction | ANP32A interactions | 3.02e-04 | 134 | 20 | 3 | int:ANP32A | |
| Interaction | PLIN3 interactions | 3.36e-04 | 139 | 20 | 3 | int:PLIN3 | |
| Interaction | DNAJB11 interactions | 3.51e-04 | 351 | 20 | 4 | int:DNAJB11 | |
| Interaction | TKT interactions | 3.59e-04 | 353 | 20 | 4 | int:TKT | |
| Interaction | PTPRO interactions | 3.65e-04 | 143 | 20 | 3 | int:PTPRO | |
| Interaction | ERP27 interactions | 4.00e-04 | 30 | 20 | 2 | int:ERP27 | |
| Interaction | TCTN1 interactions | 4.28e-04 | 151 | 20 | 3 | int:TCTN1 | |
| Interaction | VWF interactions | 4.56e-04 | 32 | 20 | 2 | int:VWF | |
| Interaction | PPME1 interactions | 4.71e-04 | 156 | 20 | 3 | int:PPME1 | |
| Interaction | MAP3K7 interactions | 4.75e-04 | 380 | 20 | 4 | int:MAP3K7 | |
| Interaction | ACP5 interactions | 5.15e-04 | 34 | 20 | 2 | int:ACP5 | |
| Interaction | CDPF1 interactions | 6.10e-04 | 37 | 20 | 2 | int:CDPF1 | |
| Interaction | PRKCZ interactions | 6.43e-04 | 412 | 20 | 4 | int:PRKCZ | |
| Interaction | LGALS8 interactions | 6.47e-04 | 174 | 20 | 3 | int:LGALS8 | |
| Interaction | DNAJB12 interactions | 6.47e-04 | 174 | 20 | 3 | int:DNAJB12 | |
| Interaction | LDLR interactions | 6.73e-04 | 417 | 20 | 4 | int:LDLR | |
| Interaction | NTM interactions | 7.14e-04 | 40 | 20 | 2 | int:NTM | |
| Interaction | PLOD2 interactions | 7.14e-04 | 180 | 20 | 3 | int:PLOD2 | |
| Interaction | FAM20C interactions | 8.10e-04 | 188 | 20 | 3 | int:FAM20C | |
| Interaction | SYNE3 interactions | 8.51e-04 | 444 | 20 | 4 | int:SYNE3 | |
| Interaction | ERP44 interactions | 8.87e-04 | 194 | 20 | 3 | int:ERP44 | |
| Interaction | MST1R interactions | 9.69e-04 | 200 | 20 | 3 | int:MST1R | |
| Interaction | DNAJB9 interactions | 9.97e-04 | 202 | 20 | 3 | int:DNAJB9 | |
| Interaction | PDIA4 interactions | 1.04e-03 | 468 | 20 | 4 | int:PDIA4 | |
| Interaction | LAIR2 interactions | 1.07e-03 | 49 | 20 | 2 | int:LAIR2 | |
| Interaction | MTSS2 interactions | 1.07e-03 | 49 | 20 | 2 | int:MTSS2 | |
| Interaction | COL12A1 interactions | 1.11e-03 | 50 | 20 | 2 | int:COL12A1 | |
| Interaction | PRDX4 interactions | 1.18e-03 | 214 | 20 | 3 | int:PRDX4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 8.27e-03 | 316 | 20 | 2 | chr3p21 | |
| GeneFamily | Protein disulfide isomerases | 3.17e-09 | 21 | 17 | 4 | 692 | |
| GeneFamily | PWWP domain containing | 1.90e-04 | 22 | 17 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 3.17e-03 | 90 | 17 | 2 | 88 | |
| GeneFamily | Ring finger proteins | 2.70e-02 | 275 | 17 | 2 | 58 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP | 3.48e-07 | 200 | 20 | 5 | M5783 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP | 1.42e-05 | 199 | 20 | 4 | M6970 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 1.45e-05 | 200 | 20 | 4 | M5787 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_DN | 1.92e-05 | 215 | 20 | 4 | M19666 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 2.46e-05 | 229 | 20 | 4 | MM16607 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 8.01e-05 | 310 | 20 | 4 | MM16608 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA | 8.40e-05 | 18 | 20 | 2 | M1680 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.11e-04 | 337 | 20 | 4 | MM16606 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP | 1.59e-04 | 140 | 20 | 3 | M2435 | |
| Coexpression | TRAVAGLINI_LUNG_GOBLET_CELL | 1.87e-04 | 148 | 20 | 3 | M41655 | |
| Coexpression | CHEN_LUNG_CANCER_SURVIVAL | 2.07e-04 | 28 | 20 | 2 | M8526 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 2.17e-04 | 1215 | 20 | 6 | M41122 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 2.17e-04 | 402 | 20 | 4 | M5275 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.63e-04 | 166 | 20 | 3 | M1542 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 2.87e-04 | 171 | 20 | 3 | M8820 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 2.88e-04 | 433 | 20 | 4 | M2240 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.28e-04 | 179 | 20 | 3 | MM660 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.54e-04 | 457 | 20 | 4 | M1613 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.94e-04 | 470 | 20 | 4 | MM1053 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN | 4.21e-04 | 195 | 20 | 3 | M8502 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 4.40e-04 | 198 | 20 | 3 | M9407 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 4.40e-04 | 198 | 20 | 3 | M3242 | |
| Coexpression | GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN | 4.47e-04 | 199 | 20 | 3 | M7690 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.47e-04 | 199 | 20 | 3 | M9420 | |
| Coexpression | GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M293 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M9953 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP | 4.53e-04 | 200 | 20 | 3 | M5131 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_DN | 4.53e-04 | 200 | 20 | 3 | M6829 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN | 4.53e-04 | 200 | 20 | 3 | M8079 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 4.53e-04 | 200 | 20 | 3 | M9336 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 4.53e-04 | 200 | 20 | 3 | M7519 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 4.53e-04 | 200 | 20 | 3 | M5777 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP | 4.53e-04 | 200 | 20 | 3 | M9536 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_DN | 4.53e-04 | 200 | 20 | 3 | M10431 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 5.15e-04 | 209 | 20 | 3 | M16036 | |
| Coexpression | VANTVEER_BREAST_CANCER_METASTASIS_UP | 5.37e-04 | 45 | 20 | 2 | M500 | |
| Coexpression | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN | 6.37e-04 | 49 | 20 | 2 | M8341 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_UP | 8.18e-04 | 245 | 20 | 3 | M7300 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 194 | 20 | 5 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 194 | 20 | 5 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 194 | 20 | 5 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-08 | 194 | 20 | 5 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.22e-06 | 183 | 20 | 4 | a6866951866373a1029e04818f4a4a31278c409d | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 183 | 20 | 4 | e32847cfebba7c8bb2026e33c3c85f64819460a9 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 183 | 20 | 4 | b5782b18decfe85026acf42daac0670d92385861 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 1.22e-06 | 183 | 20 | 4 | beadc69f511cf183e493cb445135f0748ab8b20e | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 188 | 20 | 4 | 7e27e49ec1eb02fb74c86ec2ccb84751bc778b21 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 188 | 20 | 4 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 188 | 20 | 4 | 4b14c3ad80507245564d5be96d33fd9361f67dd0 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 189 | 20 | 4 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 189 | 20 | 4 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 189 | 20 | 4 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 189 | 20 | 4 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 190 | 20 | 4 | 240923769fef18eaf73d2efa3d5f745f5533b0ce | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.42e-06 | 190 | 20 | 4 | 5ec49cc7692053c1a525ca9137c996ccd2794e1c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.42e-06 | 190 | 20 | 4 | 1f907016980ccfbf089e354d91d931771e8a83e0 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 190 | 20 | 4 | 9df9b9e91c97e504c189d6055a6aabc54ad17cec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-06 | 191 | 20 | 4 | cf217d00ba2b0402a8e72fcd64bdb36d5539dde0 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.54e-06 | 194 | 20 | 4 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.60e-06 | 196 | 20 | 4 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 173 | 20 | 3 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 173 | 20 | 3 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | droplet-Marrow-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 174 | 20 | 3 | a188ec192c378f731af1c95eb8f1392a2bb18c26 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 178 | 20 | 3 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasmablasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.72e-05 | 179 | 20 | 3 | 58c8996120637315dcbd1991a71516c09173051e | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.83e-05 | 180 | 20 | 3 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 6.94e-05 | 181 | 20 | 3 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | ILEUM-inflamed-(5)_IgA_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.17e-05 | 183 | 20 | 3 | a113558ca4220bac31f9336033dff82a618d9258 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-05 | 184 | 20 | 3 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 7.41e-05 | 185 | 20 | 3 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.41e-05 | 185 | 20 | 3 | bb87fa174f80706fe7be60d3b9fc3e2a6b373038 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 7.41e-05 | 185 | 20 | 3 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | ILEUM-non-inflamed-(5)_IgG_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.41e-05 | 185 | 20 | 3 | 93b9a47357152ea95dfdfe8e7d111906a4adc551 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | 7.53e-05 | 186 | 20 | 3 | a2c7430781f432c9c90ac4d620f4518ff767a223 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.53e-05 | 186 | 20 | 3 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | LAM-Lymphoid-B-cell-2|Lymphoid / Condition, Lineage and Cell class | 7.53e-05 | 186 | 20 | 3 | bcfe0bf2f7f745146b74496a4fcfccd869ad7c6f | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 186 | 20 | 3 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.53e-05 | 186 | 20 | 3 | 4d105437487bf04f8cd6129b822d5c060af0bee8 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.65e-05 | 187 | 20 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 7.77e-05 | 188 | 20 | 3 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.77e-05 | 188 | 20 | 3 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | ILEUM-inflamed-(5)_IgM_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.89e-05 | 189 | 20 | 3 | fa9387d120cde6416998234c6ebd0ef74deed768 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | ILEUM-inflamed-(5)_IgG_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.02e-05 | 190 | 20 | 3 | 76baa41b217ae6fd62a58971912e8ecfe1dc03e7 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 190 | 20 | 3 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.02e-05 | 190 | 20 | 3 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.02e-05 | 190 | 20 | 3 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 190 | 20 | 3 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 190 | 20 | 3 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.14e-05 | 191 | 20 | 3 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.14e-05 | 191 | 20 | 3 | dd1d38a531a272a746c16807688013d29cab823a | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.14e-05 | 191 | 20 | 3 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.14e-05 | 191 | 20 | 3 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.14e-05 | 191 | 20 | 3 | 7b4b5d90d1023d03239ed986f273afa734d3124d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.27e-05 | 192 | 20 | 3 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | remission-Plasmablast|remission / disease stage, cell group and cell class | 8.27e-05 | 192 | 20 | 3 | 4bcf22061905177ad8625b87be2fbca9bff03ec6 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.27e-05 | 192 | 20 | 3 | ec279980602292fc8ed6362edd36a5c772d59777 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.40e-05 | 193 | 20 | 3 | 902dea0bf6c2997d8b877ae01113460e511a364a | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.40e-05 | 193 | 20 | 3 | 239f2ac64f63d4d65997ba83b932a1fab1909efb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.40e-05 | 193 | 20 | 3 | 2790b245d6052063c207087b91fb9375a0e8055d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.40e-05 | 193 | 20 | 3 | 94daa8a5d23558998fe3bff585344e22ce679f2d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.40e-05 | 193 | 20 | 3 | 33dad901e0597f0057edc2bfbd64fd81f298b94e | |
| ToppCell | wk_15-18|World / Celltypes from embryonic and fetal-stage human lung | 8.40e-05 | 193 | 20 | 3 | a28ff1e80e3e741739abe869df5fbd41352a1ea0 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | 1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.40e-05 | 193 | 20 | 3 | 43ffa8ecc72bebcd204279db2bde98ae48d97f90 | |
| ToppCell | B_cell_maturation-plasma|B_cell_maturation / Lineage and Cell class | 8.40e-05 | 193 | 20 | 3 | 5415f7e54bc40aec3dbe27fd97f6e9be6db08a48 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.40e-05 | 193 | 20 | 3 | 22684aa2a368211baba79d29379d0bc442830524 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 193 | 20 | 3 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.53e-05 | 194 | 20 | 3 | 02b7911d07938f04f369a552dedc614930e4396e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma|lymph-node_spleen / Manually curated celltypes from each tissue | 8.53e-05 | 194 | 20 | 3 | 42f43cac0dec704afd18143192e3ab68360ea076 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.53e-05 | 194 | 20 | 3 | 297286c57d7ee6338d9cf77b27eb2809378ce15d | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 8.53e-05 | 194 | 20 | 3 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.53e-05 | 194 | 20 | 3 | ffba703f61faaac8b4b9a5e46cd335214303de7b | |
| ToppCell | (5)_Plasma_IgM|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.53e-05 | 194 | 20 | 3 | 47c0f7a1c39ba0836e40ea3ca8066457c0951575 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.53e-05 | 194 | 20 | 3 | 12e42433a7b7c17c46049ef450223daf2976a59a | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P|COVID-19_Convalescent / Disease group, lineage and cell class | 8.66e-05 | 195 | 20 | 3 | 4fff177aa4617060b594e637885cd0c91e7d6609 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P-Plasmablast|COVID-19_Convalescent / Disease group, lineage and cell class | 8.66e-05 | 195 | 20 | 3 | b4cfc31e4f7e899c6b2578b1ea4fbf609b7ae914 | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 8.66e-05 | 195 | 20 | 3 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.66e-05 | 195 | 20 | 3 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-05 | 196 | 20 | 3 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| ToppCell | Severe-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.79e-05 | 196 | 20 | 3 | ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.79e-05 | 196 | 20 | 3 | 0ff8cfb209063a8b217df6690ac1dec89004593f | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.79e-05 | 196 | 20 | 3 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.79e-05 | 196 | 20 | 3 | 3cf73b33330b9fca5c8abf03f2f0d8244245b522 | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.79e-05 | 196 | 20 | 3 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.79e-05 | 196 | 20 | 3 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.92e-05 | 197 | 20 | 3 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-GMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.92e-05 | 197 | 20 | 3 | 462e91dc51e363d64e1e02d7444a733838e032a5 | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 8.92e-05 | 197 | 20 | 3 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.92e-05 | 197 | 20 | 3 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-MOP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.92e-05 | 197 | 20 | 3 | 4e68a98bc7e5db7f20e865a0ca21e5a43b3cbb8f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.92e-05 | 197 | 20 | 3 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| Computational | Oxidoreductases. | 2.44e-09 | 15 | 14 | 4 | MODULE_519 | |
| Computational | Oxidoreductases. | 1.51e-03 | 182 | 14 | 3 | MODULE_93 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.72e-03 | 48 | 14 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE | |
| Drug | Dithiol | 1.61e-06 | 100 | 20 | 4 | CID000010334 | |
| Drug | tetraarsenic tetrasulfide | 1.92e-05 | 60 | 20 | 3 | ctd:C534735 | |
| Drug | betaine | 2.51e-05 | 200 | 20 | 4 | CID000000247 | |
| Drug | oxidized glutathione | 4.11e-05 | 227 | 20 | 4 | CID000000975 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 1.41e-05 | 9 | 19 | 2 | C1846707 | |
| Disease | immature platelet fraction | 2.42e-03 | 114 | 19 | 2 | EFO_0009187 | |
| Disease | immature platelet measurement | 2.64e-03 | 119 | 19 | 2 | EFO_0803541 | |
| Disease | Myocardial Ischemia | 5.66e-03 | 176 | 19 | 2 | C0151744 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HCHCNHEWAPPYCKD | 651 | O43506 | |
| GNWYCNDCKAGKKPH | 1741 | Q96L73 | |
| DEPPYCIKAGWKENH | 56 | Q5JSJ4 | |
| AGHPCYLDKPEEWHT | 186 | Q96IU4 | |
| IHCPAHCKDEPSYWA | 411 | Q9H0B8 | |
| PWCGHCKALAPEYAK | 51 | P07237 | |
| GKSWHPEEFNCAHCK | 436 | Q96HC4 | |
| CKYKRIGCPWHGPFH | 166 | Q6ZMK1 | |
| KCHHLKGNQLWEYDP | 496 | Q10472 | |
| KHPWYLGGKHEPDPC | 281 | Q8TDC3 | |
| CDYPCQQAHWPEHMK | 1046 | Q9ULU4 | |
| ECQCHPGYKLHWNKK | 426 | Q9NQ36 | |
| FYAPWCPHCKKVIPH | 421 | Q14554 | |
| HQKCPPWWYKCAHKV | 541 | P35499 | |
| FYAPWCGHCKNLEPK | 401 | P30101 | |
| LPCSHAYHCKCVDPW | 256 | O43567 | |
| FYAPWCGHCKKLAPE | 201 | P13667 | |
| CHSPWHEGVNCKEYK | 386 | Q8TC41 | |
| HYKHHWFPEKPCKGS | 51 | P62324 | |
| HTGEKPYECPVCWKA | 536 | P17025 | |
| LGEHDPWYCPNCKKH | 791 | Q13107 |